June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Correlation between higher-order aberrations and visual acuity after crosslinking treatment for keratoconus: study of 90 cases
Author Affiliations & Notes
  • Marie-Soline LUC
    Ophthalmology, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France
    Lorraine University, Nancy, France
  • SOT Maxime
    Ophthalmology, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France
    Lorraine University, Nancy, France
  • Julie Francois
    Metz-Thionville Regional Hospital Center, Mercy Hospital, Clinical Research Support Unit, France
  • Christophe Goetz
    Clinical Research Support Unit, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France
  • Nadia ouamara
    Clinical Research Support Unit, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France
  • Jean-Marc Perone
    Ophthalmology, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France
  • Footnotes
    Commercial Relationships   Marie-Soline LUC, None; SOT Maxime, None; Julie Francois, None; Christophe Goetz, None; Nadia ouamara, None; Jean-Marc Perone, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3500. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Marie-Soline LUC, SOT Maxime, Julie Francois, Christophe Goetz, Nadia ouamara, Jean-Marc Perone; Correlation between higher-order aberrations and visual acuity after crosslinking treatment for keratoconus: study of 90 cases. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3500.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The aim of our study is to analyze the correlation between higher order aberrations (HOA) of posterior corneal and visual acuity after crosslinking treatment (CXL) in advanced keratoconus

Methods : We performed an observational retrospective study including patients treated with CXL from March 2014 to April 2016. All patients received the same procedure: accelerated-CXL protocol (30 minutes of riboflavin impregnation and 10 minutes of UVA irradiation). The flowing data were assessed preoperatively and at 6 months post CXL: best corrected visual acuity, Kmax, and HOA RMS at 3, 5 and 6 mm. Included patients were splitted into 2 groups; according to their delta visual acuity: in the first group patients with decreased or stabilized visual acuity at 6 months post CXL, in the second group patients with an improvement of visual acuity. The primary endpoint was the delta RMS at 5 mm pupillary diameter. The secondary endpoints were the delta RMS at 3 and 6 mm and the delta Kmax.

Results : Eighty patients (90 eyes) were included: 50 in the decreased or stabilized visual acuity group, 40 in the improved visual acuity group at 6 months. The mean age of the patients was 26 +/- 10 years. The mean visual acuity was 0.33 +/- 0.20 logMAR before CXL and 0.29 +/- 0.19 logMAR post-CXL. The mean RMS at 5 mm was 2.67 +/- 1.3 D eq and 2.71 +/- 1.24 D eq respectively before and after CXL. The delta RMS at 5 mm was 0.01 +/- 0.69 in the improvement visual acuity group and 0.05 +/- 0.64 in the decreased or stabilized visual acuity group. There was no correlation between the visual acuity difference and the HOA (student test p = 0.76). The mean Kmax was 57.08 D and 57.37 D respectively in pre and post-treatment.

Conclusions : The analysis of the 2 groups: decrease or stabilization versus improvement of visual acuity does not therefore reveal any significant difference in the evolution of HOA RMS. It seems therefore that the improvement of the visual acuity post crosslinking is not related to a reduction of the HOA.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×